1. Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia. Koller FL, Dozier EA, Nam KT, Swee M, Birkland TP, Parks WC, Fingleton B (2012) Lab Invest 92(12): 1749-59
    › Primary publication · 23044923 (PubMed) · PMC3510327 (PubMed Central)
  2. Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters. Barrett CW, Smith JJ, Lu LC, Markham N, Stengel KR, Short SP, Zhang B, Hunt AA, Fingleton BM, Carnahan RH, Engel ME, Chen X, Beauchamp RD, Wilson KT, Hiebert SW, Reynolds AB, Williams CS (2012) PLoS One 7(12): e51205
    › Primary publication · 23251453 (PubMed) · PMC3521008 (PubMed Central)
  3. Importance of conserving middle hepatic vein distal branches for homogeneous regeneration of the left liver after right hepatectomy. Faitot F, Vibert E, Salloum C, Gorden DL, Coscas F, Adam R, Castaing D (2012) HPB (Oxford) 14(11): 746-53
    › Primary publication · 23043663 (PubMed) · PMC3482670 (PubMed Central)
  4. Epithelial nuclear factor-κB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes. Zaynagetdinov R, Stathopoulos GT, Sherrill TP, Cheng DS, McLoed AG, Ausborn JA, Polosukhin VV, Connelly L, Zhou W, Fingleton B, Peebles RS, Prince LS, Yull FE, Blackwell TS (2012) Oncogene 31(26): 3164-76
    › Primary publication · 22002309 (PubMed) · PMC3266969 (PubMed Central)
  5. Diagnostic and therapeutic challenges in hepatic epithelioid hemangioendothelioma. Mistry AM, Gorden DL, Busler JF, Coogan AC, Kelly BS (2012) J Gastrointest Cancer 43(4): 521-5
    › Primary publication · 22544493 (PubMed)
  6. Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Hallett MA, Venmar KT, Fingleton B (2012) Cancer Res 72(24): 6338-43
    › Primary publication · 23222300 (PubMed) · PMC3531868 (PubMed Central)
  7. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. Thiolloy S, Edwards JR, Fingleton B, Rifkin DB, Matrisian LM, Lynch CC (2012) PLoS One 7(1): e29862
    › Primary publication · 22238668 (PubMed) · PMC3251607 (PubMed Central)
  8. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE (2011) J Acquir Immune Defic Syndr 56(1): 64-8
    › Primary publication · 21068672 (PubMed) · PMC3017346 (PubMed Central)
  9. MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model. Barrett CW, Fingleton B, Williams A, Ning W, Fischer MA, Washington MK, Chaturvedi R, Wilson KT, Hiebert SW, Williams CS (2011) Cancer Res 71(4): 1302-12
    › Primary publication · 21303973 (PubMed) · PMC3150168 (PubMed Central)
  10. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. Gorden DL, Ivanova PT, Myers DS, McIntyre JO, VanSaun MN, Wright JK, Matrisian LM, Brown HA (2011) PLoS One 6(8): e22775
    › Primary publication · 21857953 (PubMed) · PMC3153459 (PubMed Central)